THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION.

THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION.

Therapy-related myeloid neoplasms (t-MNs) encompass a specific sub-group of myeloid malignancies arising after exposure to radio/cytotoxic agents for the treatment of unrelated diseases. Such malignancies present unique features, including advanced age, high comorbidities burden, and unfavorable...

Full description

Saved in:

Bibliographic Details
Main Authors:	Raffaele Palmieri, Ilaria Del Principe, Luca Maurillo, Adriano Venditti, Francesco Buccisano
Format:	Article
Language:	English
Published:	PAGEPress Publications 2023-08-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	t-aml T-mn Clinical evaluation
Online Access:	http://www.mjhid.org/index.php/mjhid/article/view/5428
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE
by: Gianfranco Catalano, et al.
Published: (2020-10-01)

A MULTICENTER EXPERIENCE FROM LEBANON IN CHILDHOOD AND ADOLESCENT ACUTE MYELOID LEUKEMIA:HIGH RATE OF EARLY DEATH IN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA.
by: Roula Antoine Farah
Published: (2014-12-01)

An interesting case of chronic myeloid leukemia with twists and turns
by: Thulasi Raman Ramalingam, et al.
Published: (2024-12-01)

HAPLOIDENTICAL TRANSPLANT WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASTIC SYNDROMES PATIENTS: THE ROLE OF PREVIOUS LINES OF THERAPY.
by: Daniele Avenoso, et al.
Published: (2024-01-01)

Proteogenomic characterization of highly enriched viable leukemic blasts in acute myeloid leukemia: A SWOG report
by: Jasmine Naru, et al.
Published: (2024-12-01)

AXL in myeloid malignancies – an elusive target?
by: Pia Aehnlich, et al.
Published: (2024-12-01)

Discovery of novel and potent CDK8 inhibitors for the treatment of acute myeloid leukaemia
by: Zhuoying Chen, et al.
Published: (2024-12-01)

Identification of HOXA9 methylation as an epigenetic biomarker predicting prognosis and guiding treatment choice in acute myeloid leukemia
by: Fei Xie, et al.
Published: (2025-02-01)

Identification of hub genes and immune-related pathways in acute myeloid leukemia: insights from bioinformatics and experimental validation
by: Mingliang Shan, et al.
Published: (2025-01-01)

MnSOD Mimetics in Therapy: Exploring Their Role in Combating Oxidative Stress-Related Diseases
by: Jovan Grujicic, et al.
Published: (2024-11-01)

Utilization of donor CLL-1 CAR-T cells for the treatment of relapsed of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation
by: Meng Zhang, et al.
Published: (2025-01-01)

The role of the CLL-1 protein in disease monitoring in patients diagnosed with acute myeloid leukaemia and myelodysplastic syndrome
by: Ewa Dobak, et al.
Published: (2024-10-01)

Integrated Analysis of Polymerase Family Gene Mutations in Acute Myeloid Leukemia: Clinical Features, Prognosis, and Bioinformatics Insights
by: Jianrong Wu, et al.
Published: (2024-12-01)

Loop33 × 123 CAR-T targeting CD33 and CD123 against immune escape in acute myeloid leukemia
by: Haotian Ma, et al.
Published: (2024-11-01)

Concurrent Acute Myeloid Leukemia and Autoimmune Hemolytic Anemia: Management Challenges and Clinical Insights: A Rare Case Report
by: Mais Musleh, et al.
Published: (2024-12-01)

Impact of Chemotherapy on the hematological parameters of Acute Myeloid Leukemia Iraqi patients
by: Noorhan S. Resn, et al.
Published: (2024-12-01)

Identification and validation of BATF as a prognostic biomarker and regulator of immune cell infiltration in acute myeloid leukemia
by: Zhe Zhao, et al.
Published: (2025-01-01)

The giant within: A rare case of bilateral renal angiomyolipoma surpassing 30 cm
by: Hadj Hsain ihssan, et al.
Published: (2025-04-01)

FEVER OF UNKNOWN ORIGIN AND MULTIDRUG-RESISTANT ORGANISMS COLONIZATION IN AML PATIENTS.
by: Luca Guarnera, et al.
Published: (2023-01-01)

THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION
by: Emiliano Fabiani, et al.
Published: (2023-10-01)

EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
by: Kjeld Schmiegelow
Published: (2011-01-01)

EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
by: Kjeld Schmiegelow
Published: (2011-05-01)

GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
by: Rachel Bergerson, et al.
Published: (2011-01-01)

GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
by: Angela Stoddart, et al.
Published: (2011-05-01)

MORBIDITY AND MORTALITY FROM MALIGNANT NEOPLASMS ASSOCIATED WITH HUMAN PAPILLOMAVIRUS
by: O. P. Gretsova, et al.
Published: (2017-09-01)

Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy
by: Christoforos K. Vaxevanis, et al.
Published: (2023-12-01)

A novel truncated fusion gene ETV6::AC010198.2 in post-MPN acute myeloid leukemia caused by del(12)(p13p11)
by: Jiao Lu, et al.
Published: (2025-02-01)

Discovery of novel and highly potent small molecule inhibitors targeting FLT3-ITD for the treatment of acute myeloid leukemia using structure-based virtual screening and biological evaluation
by: Kun Shi, et al.
Published: (2025-02-01)

THERAPY-RELATED MYELOID NEOPLASMS IN PATIENTS TREATED FOR HODGKIN LYMPHOMA
by: Dennis A Eichenauer, et al.
Published: (2011-10-01)

THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
by: Raffaella Marcheselli, et al.
Published: (2011-01-01)

THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
by: Alessia Bari, et al.
Published: (2011-12-01)

Rat Sarcoma Virus Family Genes in Acute Myeloid Leukemia: Pathogenetic and Clinical Implications
by: Shaimaa Khattab, et al.
Published: (2025-01-01)

The Clinical Impact of NPM1 Mutations and the Effect of Concurrent Mutations in Acute Myeloid Leukemia: Unraveling the Prognostic Significance
by: Faten Moassass, et al.
Published: (2024-12-01)

The puzzle of money laundering: a literature review of regulations and implications
by: Arina Anjani, et al.
Published: (2024-09-01)

Stem cell status and prognostic applications of cuproptosis-associated lncRNAs in acute myeloid leukemia
by: Zhuodong Chai, et al.
Published: (2025-01-01)

FREQUENCY OF FMS-LIKE TYROSINE KINASE 3 KINASE DOMAIN POINT MUTATION (FLT3/TKD MUTATION) IN DIFFERENT AGE GROUPS OF ACUTE MYELOID LEUKEMIA PATIENTS.
by: Khaleeq unnisa, et al.
Published: (2014-08-01)

Safety and efficacy of CD33-targeted CAR-NK cell therapy for relapsed/refractory AML: preclinical evaluation and phase I trial
by: Ruihao Huang, et al.
Published: (2025-01-01)

CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells
by: Lucas Touzet, et al.
Published: (2019-03-01)

THERAPY-RELATED MYELOID NEOPLASMS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND WALDENSTROM MICROGLOBULINEMIA
by: Alessandra Tedeschi, et al.
Published: (2011-01-01)

THERAPY-RELATED MYELOID NEOPLASMS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND WALDENSTROM MICROGLOBULINEMIA
by: Francesca Ricci, et al.
Published: (2011-07-01)